BACKGROUND: The short (S) allele of the serotonin transporter gene (5-HTTLPR) is associated with reduced serotonin turnover compared to the long (L) allele in Caucasians. Few studies have examined its impact on memory and brain structure in healthy young adults. METHODS: Participants included 51 healthy young adults (25 female; ages 18-25). Multiple regressions examined the independent contribution of 5-HTTLPR biomarker genotype and its interactions with gender and sub-clinical depressive symptoms on hippocampal volumes and memory. RESULTS: The 5-HTTLPR genotype significantly interacted with gender in predicting larger left hippocampal volumes in S-carrying females and smaller hippocampal volumes in males (p<.03). Gender also moderated the impact of the 5-HTTLPR on neurocognition. In females, S allele carriers had poorer visual recall compared to L carriers (p<.05). A three-way interaction between 5-HTTLPR, gender, and depressive symptoms was also observed (p<.04). In females, larger left hippocampal volumes were associated with increased depressive symptoms while the opposite was seen in males. Finally, in male and female S carriers, increased depressive symptoms were marginally associated with poorer verbal memory (p<.09). CONCLUSIONS: In females, the 5-HTTLPR S allele was associated with poorer memory performance, increased depressive symptoms and larger hippocampal volumes. In males, the S allele predicted smaller hippocampal volumes and increased depressive symptoms. The opposite morphometric patterns likely reflect gender differences in adolescent hippocampal development. Larger longitudinal studies are needed to examine whether the impact of 5-HTTLPR genotype on neurocognition across development differs according to extent of mood symptoms and gender.
BACKGROUND: The short (S) allele of the serotonin transporter gene (5-HTTLPR) is associated with reduced serotonin turnover compared to the long (L) allele in Caucasians. Few studies have examined its impact on memory and brain structure in healthy young adults. METHODS:Participants included 51 healthy young adults (25 female; ages 18-25). Multiple regressions examined the independent contribution of 5-HTTLPR biomarker genotype and its interactions with gender and sub-clinical depressive symptoms on hippocampal volumes and memory. RESULTS: The 5-HTTLPR genotype significantly interacted with gender in predicting larger left hippocampal volumes in S-carrying females and smaller hippocampal volumes in males (p<.03). Gender also moderated the impact of the 5-HTTLPR on neurocognition. In females, S allele carriers had poorer visual recall compared to L carriers (p<.05). A three-way interaction between 5-HTTLPR, gender, and depressive symptoms was also observed (p<.04). In females, larger left hippocampal volumes were associated with increased depressive symptoms while the opposite was seen in males. Finally, in male and female S carriers, increased depressive symptoms were marginally associated with poorer verbal memory (p<.09). CONCLUSIONS: In females, the 5-HTTLPR S allele was associated with poorer memory performance, increased depressive symptoms and larger hippocampal volumes. In males, the S allele predicted smaller hippocampal volumes and increased depressive symptoms. The opposite morphometric patterns likely reflect gender differences in adolescent hippocampal development. Larger longitudinal studies are needed to examine whether the impact of 5-HTTLPR genotype on neurocognition across development differs according to extent of mood symptoms and gender.
Authors: Krista Lisdahl Medina; Karen L Hanson; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert Journal: J Int Neuropsychol Soc Date: 2007-09 Impact factor: 2.892
Authors: Beverly H Brummett; Christopher L Muller; Ann L Collins; Stephen H Boyle; Cynthia M Kuhn; Ilene C Siegler; Redford B Williams; Allison Ashley-Koch Journal: Behav Genet Date: 2008-07-26 Impact factor: 2.805
Authors: J D A Olivier; L A W Jans; G A H Korte-Bouws; S M Korte; P M T Deen; A R Cools; B A Ellenbroek; A Blokland Journal: Psychopharmacology (Berl) Date: 2008-06-10 Impact factor: 4.530
Authors: T Frodl; N Koutsouleris; R Bottlender; C Born; M Jäger; M Mörgenthaler; J Scheuerecker; P Zill; T Baghai; C Schüle; R Rupprecht; B Bondy; M Reiser; H-J Möller; E M Meisenzahl Journal: Mol Psychiatry Date: 2008-07-01 Impact factor: 15.992
Authors: Jonathan P Roiser; Jamey Levy; Stephen J Fromm; Hongye Wang; Gregor Hasler; Barbara J Sahakian; Wayne C Drevets Journal: Neuropsychopharmacology Date: 2007-09-19 Impact factor: 7.853
Authors: Sarah W Feldstein Ewing; Karen A Hudson; Justin Caouette; Andrew R Mayer; Rachel E Thayer; Sephira G Ryman; Angela D Bryan Journal: Ann Behav Med Date: 2018-04-19
Authors: Jenessa S Price; Tim McQueeny; Skyler Shollenbarger; Erin L Browning; Jon Wieser; Krista M Lisdahl Journal: Psychopharmacology (Berl) Date: 2015-04-30 Impact factor: 4.530
Authors: Roberta A Schriber; Zainab Anbari; Richard W Robins; Rand D Conger; Paul D Hastings; Amanda E Guyer Journal: Clin Psychol Sci Date: 2017-05-13
Authors: Jennifer A Sumner; Suzanne Vrshek-Schallhorn; Susan Mineka; Richard E Zinbarg; Michelle G Craske; Eva E Redei; Kate Wolitzky-Taylor; Emma K Adam Journal: Cogn Emot Date: 2013-12-16
Authors: Natasha E Wright; Judith A Strong; Erika R Gilbart; Skyler G Shollenbarger; Krista M Lisdahl Journal: PLoS One Date: 2015-07-31 Impact factor: 3.240
Authors: Elisabeth M Weiss; Günter Schulter; Andreas Fink; Eva M Reiser; Erich Mittenecker; Harald Niederstätter; Simone Nagl; Walther Parson; Ilona Papousek Journal: PLoS One Date: 2014-01-20 Impact factor: 3.240
Authors: Jennifer S Richards; Alejandro Arias Vásquez; Barbara Franke; Pieter J Hoekstra; Dirk J Heslenfeld; Jaap Oosterlaan; Stephen V Faraone; Jan K Buitelaar; Catharina A Hartman Journal: PLoS One Date: 2016-05-24 Impact factor: 3.240